Select Publications
Book Chapters
2014, 'Proteomic techniques to detect urinary biomarkers in breast cancer', in Makowski G (ed.), Advances in Clinical Chemistry, Elsevier, pp. 123 - 167, http://www.sciencedirect.com/science/bookseries/00652423/63/supp/C
,2013, 'Tear as a source of protein biomarkers for human disease diagnosis and prognosis', in Makowski G (ed.),
,2012, 'Prostate Cancer Biomarkers and the Emerging Proteomic Techniques Used in Biomarker Research', in Watanabe HS (ed.), Horizons in Cancer Research Vol 47, Nova Science Publishers Inc, New York, pp. 1 - 36, https://www.novapublishers.com/catalog/product_info.php?products_id=27295
,2011, 'Angiogenesis, Lymphangiogenesis and Vasculogenic Mimicry in Human Prostate Cancer Therapy', in Berhardt LV (ed.), Advances in Medicine and Biology, edn. Volume 38, Nova Science Publishers, Inc., New York, USA, pp. 49 - 90, https://www.novapublishers.com/catalog/product_info.php?products_id=32769
,2010, 'Biomarkers for radiosensitivity and radiosensitivity targets in prostate cancer', in Nguyen SD (ed.), Tumour Suppressors, Nova Science Publishers, USA, pp. 189 - 228
,2003, 'Targeted Alpha Therapy of Prostate Cancer', in Russell PJ (ed.), Prostrate Cancer Methods and Protocols, Humana Press, Totowa, new Jersey, pp. 333 - 357
,1997, 'Growth factors modulating human mast cell growth and function', in Seminars in Clinical Immunology, edn. Original, Edizioni Grafiche Mazzucchelli S.B.L., Italy, pp. 17 - 24
,Journal articles
2024, 'Optimising Extracellular Vesicle Metabolomic Methodology for Prostate Cancer Biomarker Discovery', Metabolites, 14, http://dx.doi.org/10.3390/metabo14070367
,2024, 'Prostate cancer-derived extracellular vesicles metabolic biomarkers: Emerging roles for diagnosis and prognosis', Journal of Controlled Release, 371, pp. 126 - 145, http://dx.doi.org/10.1016/j.jconrel.2024.05.029
,2024, 'Proteomic Identification of Small Extracellular Vesicle Proteins LAMB1 and Histone H4 for Prostate Cancer Diagnosis and Risk Stratification', Advanced Science, 11, http://dx.doi.org/10.1002/advs.202402509
,2024, 'Consensus statement on extracellular vesicles in liquid biopsy for advancing laboratory medicine', Clinical Chemistry and Laboratory Medicine, http://dx.doi.org/10.1515/cclm-2024-0188
,2023, 'Hypoxic tumor cell-derived small extracellular vesicle miR-152-3p promotes cervical cancer radioresistance through KLF15 protein', Radiation Oncology, 18, http://dx.doi.org/10.1186/s13014-023-02369-3
,2023, 'Prostate cancer-derived small extracellular vesicle proteins: the hope in diagnosis, prognosis, and therapeutics', Journal of Nanobiotechnology, 21, http://dx.doi.org/10.1186/s12951-023-02219-0
,2023, 'Recent advances of small extracellular vesicle biomarkers in breast cancer diagnosis and prognosis', Molecular Cancer, 22, http://dx.doi.org/10.1186/s12943-023-01741-x
,2023, 'Comparison Study of Small Extracellular Vesicle Isolation Methods for Profiling Protein Biomarkers in Breast Cancer Liquid Biopsies', International Journal of Molecular Sciences, 24, http://dx.doi.org/10.3390/ijms242015462
,2023, 'Extracellular vesicles as a novel approach for breast cancer therapeutics', Cancer Letters, 555, http://dx.doi.org/10.1016/j.canlet.2022.216036
,2023, 'Aldolase A promotes cervical cancer cell radioresistance by regulating the glycolysis and DNA damage after irradiation', Cancer Biology and Therapy, 24, http://dx.doi.org/10.1080/15384047.2023.2287128
,2023, 'Treatment strategies for intrauterine adhesion: focus on the exosomes and hydrogels', Frontiers in Bioengineering and Biotechnology, 11, http://dx.doi.org/10.3389/fbioe.2023.1264006
,2022, 'Inhibition of Autophagy Promotes the Elimination of Liver Cancer Stem Cells by CD133 Aptamer-Targeted Delivery of Doxorubicin', Biomolecules, 12, http://dx.doi.org/10.3390/biom12111623
,2022, 'Recent progress of the tumor microenvironmental metabolism in cervical cancer radioresistance', Frontiers in Oncology, 12, http://dx.doi.org/10.3389/fonc.2022.999643
,2022, 'Recent advances of non-coding RNAs in ovarian cancer prognosis and therapeutics', THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 14, http://dx.doi.org/10.1177/17588359221118010
,2022, 'Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion', Cell Death and Disease, 13, http://dx.doi.org/10.1038/s41419-022-04510-8
,2022, 'Liquid biopsy of extracellular vesicle biomarkers for prostate cancer personalized treatment decision', Extracellular Vesicles and Circulating Nucleic Acids, 3, pp. 3 - 9, http://dx.doi.org/10.20517/evcna.2021.20
,2021, 'THOC2 and THOC5 Regulate Stemness and Radioresistance in Triple-Negative Breast Cancer', Advanced Science, 8, http://dx.doi.org/10.1002/advs.202102658
,2021, 'The Emerging Role of Exosomes in Cancer Chemoresistance', Frontiers in Cell and Developmental Biology, 9, http://dx.doi.org/10.3389/fcell.2021.737962
,2021, 'Tumor-Derived Exosomal Protein Tyrosine Phosphatase Receptor Type O Polarizes Macrophage to Suppress Breast Tumor Cell Invasion and Migration', Frontiers in Cell and Developmental Biology, 9, http://dx.doi.org/10.3389/fcell.2021.703537
,2021, 'Immunotherapy for triple-negative breast cancer: A molecular insight into the microenvironment, treatment, and resistance', Journal of the National Cancer Center, 1, pp. 75 - 87, http://dx.doi.org/10.1016/j.jncc.2021.06.001
,2021, 'Emerging Role of Exosomes in Liquid Biopsy for Monitoring Prostate Cancer Invasion and Metastasis', Frontiers in Cell and Developmental Biology, 9, http://dx.doi.org/10.3389/fcell.2021.679527
,2021, 'Activation of the eIF2 alpha/ATF4 axis drives triple-negative breast cancer radioresistance by promoting glutathione biosynthesis', REDOX BIOLOGY, 43, http://dx.doi.org/10.1016/j.redox.2021.101993
,2021, 'Triple-negative breast cancer therapeutic resistance: Where is the Achilles' heel?', Cancer Letters, 497, pp. 100 - 111, http://dx.doi.org/10.1016/j.canlet.2020.10.016
,2020, 'Long Non-Coding RNAs: The Regulatory Mechanisms, Research Strategies, and Future Directions in Cancers', Frontiers in Oncology, 10, http://dx.doi.org/10.3389/fonc.2020.598817
,2020, 'Exosomes and breast cancer drug resistance', Cell Death and Disease, 11, http://dx.doi.org/10.1038/s41419-020-03189-z
,2020, 'A Clinician's Guide to Cancer-Derived Exosomes: Immune Interactions and Therapeutic Implications', Frontiers in Immunology, 11, pp. 1612, http://dx.doi.org/10.3389/fimmu.2020.01612
,2020, 'Exosomes and Nanoengineering: A Match Made for Precision Therapeutics', Advanced Materials, 32, http://dx.doi.org/10.1002/adma.201904040
,2020, 'CD44 variant 6 is associated with prostate cancer growth and chemo-/radiotherapy response in vivo', Experimental Cell Research, 388, http://dx.doi.org/10.1016/j.yexcr.2020.111850
,2020, 'Aptamer-guided extracellular vesicle theranostics in oncology', Theranostics, 10, pp. 3849 - 3866, http://dx.doi.org/10.7150/thno.39706
,2020, 'Exosomal microRNAs as liquid biopsy biomarkers in prostate cancer', Critical Reviews in Oncology/Hematology, 145, http://dx.doi.org/10.1016/j.critrevonc.2019.102860
,2020, 'Extracellular vesicles: The next generation of biomarkers for liquid biopsy-based prostate cancer diagnosis', Theranostics, 10, pp. 2309 - 2326, http://dx.doi.org/10.7150/thno.39486
,2020, 'Quality assessment and comparison of plasma-derived extracellular vesicles separated by three commercial kits for prostate cancer diagnosis', International Journal of Nanomedicine, 15, pp. 10241 - 10256, http://dx.doi.org/10.2147/IJN.S283106
,2019, 'Cancer stem cells in prostate cancer radioresistance', Cancer Letters, 465, pp. 94 - 104, http://dx.doi.org/10.1016/j.canlet.2019.08.020
,2019, 'Exosomes in Cancer Radioresistance', Frontiers in Oncology, 9, http://dx.doi.org/10.3389/fonc.2019.00869
,2019, 'Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression', BMC Cancer, 19, http://dx.doi.org/10.1186/s12885-019-5824-9
,2019, 'A Detailed Protein-SELEX Protocol Allowing Visual Assessments of Individual Steps for a High Success Rate', Human Gene Therapy Methods, 30, pp. 1 - 16, http://dx.doi.org/10.1089/hgtb.2018.237
,2019, 'CHTOP in chemoresistant epithelial ovarian cancer: A novel and potential therapeutic target', Frontiers in Oncology, 9, pp. 557, http://dx.doi.org/10.3389/fonc.2019.00557
,2019, 'In Vivo 3D MRI Measurement of Tumour Volume in an Orthotopic Mouse Model of Prostate Cancer', Cancer Control, 26, http://dx.doi.org/10.1177/1073274819846590
,2019, 'Liquid biopsy in ovarian cancer: Recent advances in circulating extracellular vesicle detection for early diagnosis and monitoring progression', Theranostics, 9, pp. 4130 - 4140, http://dx.doi.org/10.7150/thno.34692
,2018, 'Epithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo', BMC Cancer, 18, pp. 1092, http://dx.doi.org/10.1186/s12885-018-5010-5
,2018, 'Cancer stem cell in breast cancer therapeutic resistance', Cancer Treatment Reviews, 69, pp. 152 - 163, http://dx.doi.org/10.1016/j.ctrv.2018.07.004
,2017, 'Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells', Scientific Reports, 7, pp. 5898, http://dx.doi.org/10.1038/s41598-017-05859-z
,2017, 'Urinary biomarkers in prostate cancer detection and monitoring progression', Critical Reviews in Oncology/Hematology, 118, pp. 15 - 26, http://dx.doi.org/10.1016/j.critrevonc.2017.08.002
,